跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
GELNIQUE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
GELNIQUE
Authorized
STANDARD
GELNIQUE
WATSON LABORATORIES, INC.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
d436073ef308b999
Company
WATSON LABORATORIES, INC.
Type
Standard
Approval Details
Approval Id
d436073ef308b999
Drug Approval Canada Name
GELNIQUE
Product Name
GELNIQUE
Status
Cancelled Pre Market
Status Date
2018-09-12
Din
02366142
Drug Class
Human
Dosage Form
Metered-Dose Pump
Route Of Administration
Topical
Schedule
Prescription
Ahfs
86:12.04
Atc Original
G04BD04 OXYBUTYNIN
Atc Name
g 04 bd 04
Aig Number
0114692006
Company Name
WATSON LABORATORIES, INC.
Company Address
85 Enterprise Blvd, Sutie 500, Markham, Ontario, Canada, L6G 0B5
Company Detail Path
/organization/watson-laboratories-inc
Company Information
Pharmaceutical Company Name
WATSON LABORATORIES, INC.
Country Name
United States
Province Name
Utah
City Name
salt lake city,utah,country_us
Address
577 S Chipeta Way
Active Ingredients
OXYBUTYNIN CHLORIDE
100 MG / G
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
d436073ef308b999
Type
Standard
Back to Health Canada Approvals